2 weeks Bristol Myers Wallops Fourth-Quarter Views, But Shares Slide On 2025 Outlook Investor's Business Daily

Bristol Myers walloped sales views Thursday, but Bristol Myers Squibb stock took a hit on a light outlook hamstrung by generic competition.
The post Bristol Myers Wallops Fourth-Quarter Views, But Shares Slide On 2025 Outlook appeared first on Investor…